Latest market price
3.83
-0.20-4.96%
RXRXQT37Recursion Pharmaceuticals, Inc.·NASDAQ
3.83-4.96%

Latest SEC Filings

Form category
DescriptionFilingDocument
Nov 02, 20268-KCurrent report
Nov 02, 202610-QQuarterly report
Oct 15, 20268-KCurrent report
Oct 15, 2026424B5Prospectus
Oct 15, 2026424B5Prospectus
Oct 07, 20264Statement of changes in beneficial ownership
Oct 07, 20264Statement of changes in beneficial ownership
Oct 02, 20264Statement of changes in beneficial ownership
Oct 02, 20264Statement of changes in beneficial ownership
Sep 21, 20268-KCurrent report
Sep 16, 20264Statement of changes in beneficial ownership
Sep 10, 20264Statement of changes in beneficial ownership
Sep 02, 20264Statement of changes in beneficial ownership
Aug 18, 20264Statement of changes in beneficial ownership
Aug 18, 20264Statement of changes in beneficial ownership
Aug 18, 20264Statement of changes in beneficial ownership
Aug 07, 2026SC 13GBeneficial ownership statement (passive)
Aug 06, 20264Statement of changes in beneficial ownership
Aug 05, 20268-KCurrent report
Aug 05, 202610-QQuarterly report
Jul 31, 2026SC 13GBeneficial ownership statement (passive)
Jul 31, 2026SC 13GBeneficial ownership statement (passive)
Jul 29, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 09, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership